CD133, a lung cancer and glioma stem cell marker, is sometimes inactivated in both tumor types because of CpG island methylation.28 Thus, CD133 may not be expressed in all lung or glioma tumors or may not be uniformly expressed in all sections of the same tumor. This evidence concerns the gene PROM1 and central nervous system cancer.